U.S. Down Syndrome Market to 2032
Overview
The U.S. Down Syndrome Market is expected to reach a 3.46 USD Billion by 2032 and is projected to grow at a CAGR of 23.61% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.15
Forecast, 2032 (USD Billion)
3.46
CAGR, 2024 - 2032
23.61%
Report Coverage
U.S.
U.S. Down Syndrome Market 2018-2032 USD Billion
U.S. Down Syndrome Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.15 USD Billion
- Projected Market Size (2032): 3.46 USD Billion
- CAGR (2025-2032): 23.61%
Key Findings of U.S. Down Syndrome Market
- The U.S. Down Syndrome Market was valued at 1.15 USD Billion in 2024.
- The U.S. Down Syndrome Market is likely to grow at a CAGR of 23.61% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Trisomy 21 in Disease Type Segment accounted for the largest share of the market with a revenue of 1.07 USD Billion
- The fastest growing segment Therapy Centers in End User Segment grew Fastest with a CAGR of 27.71% during the forecast period from 2024 to 2032.
U.S. Down Syndrome Market Scope
U.S. Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
U.S. Down Syndrome Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.15 USD Billion |
| Market Value in 2032 | 3.46 USD Billion |
| CAGR (2025-2032) | 23.61% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment, Disease Type, Distribution Channel, End User |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 1.15 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,148.42 USD Million in 2024.
Segments and Scope
-
U.S. Down Syndrome Market to 2032, By Treatment
- Diagnosis is the largest segment in U.S. Down Syndrome Market to 2032 with a revenue of 1.01 USD Billion in the year 2024.
- Therapy is the Fastest growing segment in U.S. Down Syndrome Market to 2032 with a Growth rate of 23.26 % in forecast period 2025-2032.
-
U.S. Down Syndrome Market to 2032, By Disease Type
- Trisomy 21 is the largest segment in U.S. Down Syndrome Market to 2032 with a revenue of 1.07 USD Billion in the year 2024.
- Trisomy 21 is the Fastest growing segment in U.S. Down Syndrome Market to 2032 with a Growth rate of 23.93 % in forecast period 2025-2032.
-
U.S. Down Syndrome Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Down Syndrome Market to 2032 with a revenue of 901.41 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Down Syndrome Market to 2032 with a Growth rate of 24.84 % in forecast period 2025-2032.
-
U.S. Down Syndrome Market to 2032, By End User
- Hospital is the largest segment in U.S. Down Syndrome Market to 2032 with a revenue of 650.07 USD Billion in the year 2024.
- Therapy Centers is the Fastest growing segment in U.S. Down Syndrome Market to 2032 with a Growth rate of 23.10 % in forecast period 2025-2032.
U.S. Down Syndrome Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
U.S. Down Syndrome Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Down Syndrome Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, Distribution Channel, End User.
U.S. Down Syndrome Market was valued at USD 1.15(Revenue in USD Billion) in 2020.
U.S. Down Syndrome Market is projected to grow at a CAGR of 23.61% during the forecast period of 2024 to 2032.
The Trisomy 21 segment is expected to dominate the U.S. Down Syndrome Market, holding a largest market share of 1.07 USD Billion in 2024
U.S. Down Syndrome Market Scope
U.S. Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Frequently Asked Questions
The U.S. Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, Distribution Channel, End User.
U.S. Down Syndrome Market was valued at USD 1.15(Revenue in USD Billion) in 2020.
U.S. Down Syndrome Market is projected to grow at a CAGR of 23.61% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Down Syndrome Market for final year is USD 3.46 (USD Billion).
U.S. Down Syndrome Market Company Profiling
Frequently Asked Questions
The U.S. Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, Distribution Channel, End User.
U.S. Down Syndrome Market was valued at USD 1.15(Revenue in USD Billion) in 2020.
U.S. Down Syndrome Market is projected to grow at a CAGR of 23.61% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Down Syndrome Market for final year is USD 3.46 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.